Cleared Traditional

K842783 - ACA BARBITURATES SCREEN ANALY TEST PACK

K842783 is the FDA 510(k) clearance for ACA BARBITURATES SCREEN ANALY TEST PACK by E.I. Dupont DE Nemours & Co., Inc.. It is a Class 2 Toxicology device (product code DIS) cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K842783 · E.I. Dupont DE Nemours & Co., Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
52d
Days
Class 2
Risk

K842783 is an FDA 510(k) clearance for the ACA BARBITURATES SCREEN ANALY TEST PACK. Classified as Enzyme Immunoassay, Barbiturate (product code DIS), Class II - Special Controls.

Submitted by E.I. Dupont DE Nemours & Co., Inc. (Mchenry, US). The FDA issued a Cleared decision on September 7, 1984 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3150 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all E.I. Dupont DE Nemours & Co., Inc. devices

Submission Details

510(k) Number K842783 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 1984
Decision Date September 07, 1984
Days to Decision 52 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 87d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DIS Enzyme Immunoassay, Barbiturate
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DIS Enzyme Immunoassay, Barbiturate

All 67
Devices cleared under the same product code (DIS) and FDA review panel - the closest regulatory comparables to K842783.
ABUSCREEN (R) EIA BARBITURATE
K870378 · Roche Diagnostic Systems, Inc. · Mar 1987
EMIT D.A.U. BARBITURATE ASSAY
K842675 · Syva Co. · Sep 1984
EMIT 700 BARBITURATE ASSAY
K843418 · Syva Co. · Sep 1984
EMIT ST SERUM BARBITURATE ASSAY
K840194 · Syva Co. · Mar 1984
MODIF. OF EMIT URINE BARBITURATE
K833577 · Syva Co. · Jan 1984
EMIT-ST SERUM BARBITURATE ASSAY
K810602 · Syva Co. · Apr 1981